Correction of pruritus in patients with pruritic dermatoses, senile and idiopathic pruritus

Close metadata

The paper summarizes the main data on etiology and pathogenesis of skin itching. Skin itching is nowadays a very common symptom, but it is often out of the clinician's area of focus because of the limited possibilities of differential diagnosis. Idiopathic and senile prurituses, for which the means and possibilities for treatment are limited, hold a prominent place in this group of disorders. Material and methods. The clinical aspects of Gistafen (sequifenadin) in the complex treatment of chronic diseases associated with pruritus, in particular senile and idiopathic pruritus, in ambulatory practice were studied. Results. Inclusion of Gistafen in the complex therapy of pruritus demonstrates high clinical efficacy, rapid elimination of symptoms, significant improvement in the quality of life of patients and their adherence to treatment. Conclusions. Sequifenadin (Gistafen) has a pronounced antipruritic effect and high safety profile. It has higher priority as compared to first- and second-generation antihistamines.

Keywords:

histamine

Gistafen

sequifenadin

pruritus

senile pruritus

idiopathic pruritus

itching dermatitis

allergic dermatitis

Authors:

Vialov S.S.

Evropeĭskiĭ meditsinskiĭ tsentr, Moskva, 123104, Rossiĭskaia Federatsiia

Drozdova G.A.

Rossiĭskiĭ universitet druzhby narodov, Moskva, 117198, Rossiĭskaia Federatsiia

List of references:

Raap U., Ständer S., Metz M. Pathophysiology of itch and new treatments. Curr Opin Allergy Clin Immunol 2011; 11: 420.
Ständer S., Schäfer I., Phan N.Q. et al. Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730. Dermatoljgy 2010; 221: 229.
Dalgard F., Svensson A., Holm J.О., Sundby J. Self-reported skin morbidity among adults: associations with quality of life and general health in a Norwegian survey. J Invest Dermatol Symp Proc 2004; 9: 120.
Schmelz M., Schmidt R., Bickel A., et al. Specific C-receptors for itch in human skin. J Neurosci 1997; 17: 8003.
Reddy V.B., Iuga A.O., Shimada S.G. et al. Cowhage-evoked itch is mediated by a novel cysteine protease: a ligand of protease-activated receptors. J Neurosci 2008; 28: 4331.
Sun Y.G., Zhao Z.Q., Meng X.L. et al. Cellular basis of itch sensation. Science 2009; 325: 1531.
Davidson S., Zhang X., Yoon C.H. et al. The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J Neurosci 2007; 27: 10007.
Yosipovitch G. The pruritus receptor unit: a target for novel therapies. J Invest Dermatol 2007; 127: 1857.
Davidson S., Giesler G.J. The multiple pathways for itch and their interactions with pain. Trends Neurosci 2010; 33: 550.
Namer B., Carr R., Johanek L.M. et al. Separate peripheral pathways for pruritus in man. J Neurophysiol 2008; 100: 2062.
Metz M., Ständer S. Chronic pruritus-pathogenesis, clinical aspects and treatment. J Eur Acad Dermatol Venereol 2010; 24: 1249.
Ikoma A., Steinhoff M., Ständer S. et al. The neurobiology of itch. Nat Rev Neurosci 2006; 7: 535.
Ständer S., Weisshaar E., Mettang T. et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Dermatol Venereol 2007; 87: 291.
Yosipovitch G., Bernhard J.D. Clinical practice. Chronic pruritus. N Engl J Med 2013; 368: 1625.
Patel T., Yosipovitch G. The management of chronic pruritus in the elderly. Skin Therapy Lett 2010; 15: 5.
Namer B. Age related changes in human C-fiber function. Neurosci Lett 2010; 470: 185.
Patel T., Yosipovitch G. The management of chronic pruritus in the elderly. Skin Therapy Lett 2010; 15: 5.
Greco P.J., Ende J. Pruritus: a practical approach. J Gen Intern Med 1992; 7: 340.
Papa C.M. Winter itch, dry skin. J Med Soc N Y 1980; 77: 817.
Grattan C.E., Sabroe R.A., Greaves M.W. Chronic urticaria. J Am Acad Dermatol 2002; 46: 645.
Razykov I., Thombs B.D., Hudson M. et al. Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. Arthritis Rheum 2009; 61: 1765.
Yamaoka H., Sasaki H., Yamasaki H. et al. Truncal pruritus of unknown origin may be a symptom of diabetic polyneuropathy. Diabet Care 2010; 33: 150.
Pujol R.M., Gallardo F., Llistosella E. et al. Invisible mycosis fungoides: a diagnostic challenge. J Am Acad Dermatol 2002; 47: S168.
Van Os-Medendorp H., Ros W.J., Eland-de Kok P.C. et al. Effectiveness of the nursing programme 'Coping with itch': a randomized controlled study in adults with chronic pruritic skin disease. Br J Dermatol 2007; 156: 1235.
Gieler U., Niemeier V., Brosig B., Kupfer J. Psychosomatic aspects of pruritus. In: Itch: Basic Mechanisms and Therapy. Eds. G. Yosipovitch, M.W. Greaves, A.B.Jr. Fleischerr, F. McGlone. New York: Marcel Dekker 2004.
Yamamoto Y., Yamazaki S., Hayashino Y. et al. Association between frequency of pruritic symptoms and perceived psychological stress: a Japanese population-based study. Arch Dermatol 2009; 145: 1384.
Yosipovitch G., Goon A., Wee J. et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 2000; 143: 969.
Yosipovitch G., Goon A.T., Wee J. et al. Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus. Int J Dermatol 2002; 41: 212.
Pfab F., Huss-Marp J., Gatti A. et al. Influence of acupuncture on type I hypersensitivity itch and the wheal and flare response in adults with atopic eczema - a blinded, randomized, placebo-controlled, crossover trial. Allergy 2010; 65: 903.
Kim K.H., Lee M.S., Choi S.M. Acupuncture for treating uremic pruritus in patients with end-stage renal disease: a systematic review. J Pain Symptom Manag 2010; 40: 117.
Bingham L.G., Noble J.W., Davis M.D. Wet dressings used with topical corticosteroids for pruritic dermatoses: a retrospective study. J Am Acad Dermatol 2009; 60: 792.
Papoiu A.D., Yosipovitch G. Topical capsaicin. The fire of a 'hot' medicine is reignited. Expert Opin Pharmacother 2010; 11: 1359.
Gal-Oz A., Rogowski O., Swartzon M., Kivity S. Ethyl chloride as an antipruritic agent: a double-blind placebo-controlled prospective study. Dermatology 2010; 221: 373.
Eschler D.C., Klein P.A. An evidence-based review of the efficacy of topical antihistamines in the relief of pruritus. J Drugs Dermatol 2010; 9: 992.
Metz M., Ständer S. Chronic pruritus-pathogenesis, clinical aspects and treatment. J Eur Acad Dermatol Venereol 2010; 24: 1249.
Patel T., Yosipovitch G. Therapy of pruritus. Exp Opin Pharmacother 2010; 11: 1673.
O'Donoghue M., Tharp M.D. Antihistamines and their role as antipruritics. Dermatol Ther 2005; 18: 333.
Klein P.A., Clark R.A. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999; 135: 1522.
Yosipovitch G., Bernhard J.D. Clinical practice. Chronic pruritus. N Engl J Med 2013; 368: 1625.
Greene S.L., Reed C.E., Schroeter A.L. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol 1985; 12: 669.
Перламутров Ю.Н., Ольховская К.Б., Ляпон А.О. Совершенствование терапии распространенных дерматозов у больных с нарушениями в психоэмоциональной сфере. Клин дерматол венерол 2013; 6: 119-124.
Меркулова Т.Б., Орлов Е.В., Шакшина А.А. Влияние современных анксиолитиков на качество жизни больных хроническими дерматозами. Клин дерматол венерол 2011; 6: 79-82.

Close metadata